What is the official ID of this bill?

The official print number for this legislation is HR 1026.

When did the legislative process begin?

The process officially started on 2021-02-11.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/117/bills/hr1026/BILLS-117hr1026ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Who is the primary sponsor?

The primary sponsor is Rep. Stanton, Greg [D-AZ-9].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Analysis and Potential Impact of HR 1026

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

New Opioid Warnings: Addiction and Overdose Risks

Q: What are the main provisions?

Key points include: All opioid medications will be required to carry labels warning of dependence, addiction, and overdose risks. Transferring prescribed opioid drugs to others will be explicitly defined as a prohibited act. New labeling and prohibition rules will become effective within two years of the act's enactment.

New regulations mandate clear warnings on opioid medication packaging about the risks of dependence, addiction, and overdose. This aims to increase patient awareness and reduce addiction rates. These changes will take effect within two years of the act's enactment.

Key points

All opioid medications will be required to carry labels warning of dependence, addiction, and overdose risks.

Transferring prescribed opioid drugs to others will be explicitly defined as a prohibited act.

New labeling and prohibition rules will become effective within two years of the act's enactment.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

LABEL Opioids Act

Print number: HR 1026

Sponsor: Rep. Stanton, Greg [D-AZ-9]

Process start date: 2021-02-11

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

New Opioid Warnings: Addiction and Overdose Risks

Key Questions about New Opioid Warnings: Addiction and Overdose Risks